Glucose levels during oral glucose tolerance tests and gamma-glutamyl transpeptidase are predictors of change from normal to impaired glucose tolerance in healthy middle-aged Japanese men

Acta Diabetologica

Volumn 47, Issue 3, 2010, Pages 225-230

  Watanabe, Kentaro ^a   Oba, Kenzo ^a   Suzuki, Tatsuya ^a   Okuyama, Yuu ^a   Ouchi, Motoshi ^a   Suzuki, Kazunari ^a   Ohnishi, Tetsuro ^a   Hashimoto, Masao ^a   Igari, Yoshimasa ^a   Nakano, Hiroshi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

GGT; Impaired glucose tolerance; OGTT

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; GLUCOSE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; JAPANESE; MALE; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEALTH; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 77955662136     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-009-0122-7     Document Type: Article

References (30)

1. ELM Barr PZ Zimmet TA Welborn, et al. 2007 Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance. The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) Circulation 116 151 157 10.1161/CIRCULATIONAHA.106. 685628 1:CAS:528:DC%2BD2sXntlWqurg%3D 17576864 (Pubitemid 47057520)
2. M Tominaga K Igarashi H Eguchi T Kato H Manaka A Sekikawa 1999 Impaired glucose tolerance is a risk factor for cardiovascular diseases, but not impaired fasting glucose: the Funagata Diabetes Study Diabetes Care 22 920 924 10.2337/diacare.22.6.920 1:STN:280:DyaK1MzgtVygsg%3D%3D 10372242 (Pubitemid 29241045)
3. The DECODE study group on behalf of the European Diabetes Epidemiology Group 1999 Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria Lancet 354 617 621 10.1016/S0140- 6736(98)12131-1 (Pubitemid 29391424)
4. World Health Organization: diabetes mellitus (1985) report of a WHO study Group. Tech Rep, Ser., no. 727, Geneva
5. Y Igarashi T Mita R Mizuno, et al. 2005 Characteristics of Japanese subjects who progress from normal to impaired glucose tolerance. Longitudinal study excluding change in body weight Endocr J 52 683 689 10.1507/endocrj.52.683 16410659 (Pubitemid 43104671)
6. MF Saad WC Knowler DJ Pettitt RG Nelson MA Charles PH Bennett 1999 A two-step model for development of non-insulin-dependent diabetes Am J Med 90 229 235
7. C Weyer C Bogardus DM Mott RE Pratley 1999 The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus J Clin Invest 104 787 794 10.1172/JCI7231 1:CAS:528: DyaK1MXmtFGltbg%3D 10491414
8. E Ferrannini A Gastaldelli Y Miyazaki, et al. 2003 Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance Diabetologia 46 1211 1219 10.1007/s00125-003-1169-6 1:CAS:528:DC%2BD3sXmvFCitbc%3D 12879253 (Pubitemid 37214979)
9. A Kurose M Fukushima M Usami 2003 Impaired beta-cell function and insulin sensitivity in Japanese subjects with normal glucose tolerance Diabetes Res Clin Pract 59 71 77 10.1016/S0168-8227(02)00177-8 12482644 (Pubitemid 35461912)
10. K Matsumoto Y Yoshihiko S Miyake, et al. 1997 Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects Diabetes Care 22 1562 1568 10.2337/diacare.20.10.1562
11. H Suzuki M Fukushima M Usami, et al. 2003 Factors responsible for development from normal glucose tolerance to isolated postchallenge hyperglycemia Diabetes Care 26 1211 1215 10.2337/diacare.26.4.1211 1:CAS:528:DC%2BD3sXjtVOis7Y%3D 12663599 (Pubitemid 36929274)
12. T Hirose R Mizuno T Yoshimoto 2002 The effects of nateglinide following oral glucose load in impaired glucose tolerance subjects: rapid insulin stimulation by nateglinide in IGT subjects Endocr J 49 649 652 10.1507/endocrj.49.649 1:CAS:528:DC%2BD3sXhslOntL8%3D 12625415 (Pubitemid 36119585)
13. D-H Lee DR Jacobs M Gross, et al. 2003 γ-Glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) study Clin Chem 49 1358 1366 10.1373/49.8.1358 1:CAS:528:DC%2BD3sXlvF2ntrY%3D 12881453 (Pubitemid 36900623)
14. N Nakanishi K Suzuki K Tatara 2004 Serum γ-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men Diabetes Care 27 1427 1432 10.2337/diacare.27.6.1427 1:CAS:528: DC%2BD2cXlt1yluro%3D 15161799 (Pubitemid 38679993)
15. SG Wannamethee AG Shaper L Lennon PH Whincup 2005 Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men Diabetes Care 28 2913 2918 10.2337/diacare.28.12.2913 1:CAS:528:DC%2BD28XhsFI%3D 16306554 (Pubitemid 43942924)
16. K Takahashi H Uchiyama S Yanagisawa S Kaname 2006 The logistic regression and ROC analysis of group-based screening for predicting diabetes incidence in four years Kobe J Med Sci 52 171 180 1:CAS:528:DC%2BD2sXltFWltr8%3D 17329955
17. ES Ford MB Schulze MM Bergmann C Thamer H-G Joost H Boeing 2008 Liver enzymes and incident diabetes: findings from the European Prospective Investigation In to Cancer and Nutrition (EPIC)-Potsdam Study Diabetes Care 31 1138 1143 10.2337/dc07-2159 18346992
18. A Hanley K Williams A Festa, et al. 2004 Elevations in markers of liver injury and risk of type 2 diabetes Diabetes 53 2623 2632 10.2337/diabetes.53.10. 2623 1:CAS:528:DC%2BD2cXotFymt78%3D 15448093 (Pubitemid 39299271)
19. N Sattar O Scherbakova I Ford, et al. 2004 Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the West of Scotland Coronary Prevention Study Diabetes 53 2855 2860 10.2337/diabetes.53.11.2855 1:CAS:528:DC%2BD2cXpvV2it7c%3D 15504965 (Pubitemid 39425910)
20. AO Rantala M Lilja H Kauma MJ Savolainen A Reunanen 2000 Gamma-glutamyl transpeptidase and the metabolic syndrome J Intern Med 248 230 238 10.1046/j.1365-2796.2000.00723.x 1:CAS:528:DC%2BD3cXmvVWmsrk%3D 10971790
21. M Orisawa N Nakai T Makoto A Suwabe 2006 Risk factors for development of pre-diabetic state from normal glucose regulation Tohoku J Exp Med 210 279 283 10.1620/tjem.210.279 (Pubitemid 44883967)
22. C Loguercio T De Simone MV D'Auria, et al. 2004 Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver Dig Liver Dis 36 398 405 1:STN:280:DC%2BD2czksFGnsA%3D%3D 15248380
23. G Marchesini G Forlani 2002 NASH: from liver diseases to metabolic disorders and back to clinical hepatology Hepatology 35 497 499 10.1053/jhep.2002.31551 11826428 (Pubitemid 34106393)
24. SDH Malnick M Beergabel H Knobler 2003 Non-alcoholic fatty liver: a common manifestation of a metabolic disorder Q J M 96 699 709 1:STN:280:DC%2BD3svktF2jug%3D%3D
25. C Su K Wang T Hsia C Chen T Tung 2006 Association of nonalcoholic fatty liver disease with abnormal aminotransferase and postprandial hypertension J Clin Gastroenterol 40 551 554 10.1097/00004836-200607000-00015 1:CAS:528:DC%2BD28XmsFOnu7o%3D 16825939 (Pubitemid 44318141)
26. P André B Balkau C Born E Charles E Eschwège 2006 Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort Diabetologia 49 2599 2603 10.1007/s00125-006-0418-x 16969645
27. C Weyer PA Tataranni C Bogardus RE Pratley 2001 Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development Diabetes Care 24 89 94 10.2337/diacare.24.1.89 1:CAS:528:DC%2BD3MXkvVKlug%3D%3D 11194248
28. GS Hotamisligil 2003 Inflammatory pathways and insulin action Int J Obes 27 S53 S55 10.1038/sj.ijo.0802502 1:CAS:528:DC%2BD2cXls1Ki (Pubitemid 38019190)
29. A Ceriello E Motz 2004 Is oxidative stress the pathologic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited Arterioscler Thromb Vasc Biol 24 816 823 10.1161/01.ATV.0000122852.22604.78 1:CAS:528:DC%2BD2cXjsFSntLo%3D 14976002 (Pubitemid 38620857)
30. D-H Lee R Blomhoff DR Jacobs 2004 Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 38 535 539 10.1080/ 10715760410001694026 1:CAS:528:DC%2BD2cXksFaktLc%3D 15346644 (Pubitemid 38697087)